There is no longer a place for underage cytology in genitourinary medicine clinics
In 1971, Cochrane and Holland' published a paper in which they highlighted the difference between a clinical consultation and screening procedures we believe there is an ethical difference between everyday medical practice and screening. If a patient asks a medical practitioner for help, the doctor does the best he can. He is not responsible for defects in medical knowledge. If, however, the practitioner initiates the screening procedures he is in a very different situation. He should, in our view, have conclusive evidence that screening can alter the natural history of disease in a significant proportion of those screened. In his recent paper, McCormick2 goes further and states that the degree of certainty should be much greater in matters ofpublic health than in the conduct of the ordinary clinical consultation. We must have absolute proof of the cost (not just financial) benefit ratio before imposing a screening test on a patient.
Before discussing the merits of cervical cytology in the under 20s, it should be pointed out that even in the older higher risk age groups there is continuing debate as to whether the cervical screening programme is the success story it is often claimed to be. Raffle et a13 published their results on 255 000 women served by the Bristol screening programme. The organisation was good and the population uptake had been high. Nearly 6000 women were referred for colposcopy and they concluded that this number was excessively high in comparison with the incidence of the malignancy they were trying to prevent. Their programme is identifying 1 in 10 young women as "at risk"for a disease that is likely to affect one in many thousands. Our mortality data suggests that the effect ofscreening, even with good population coverage, staff training and quality assurance, is too small to discern in a population of 114 million women, yet both Iceland and Aberdeen (where clear effects from screening have been claimed) has smaller populations. We must simply live with the fact that we can never know for certain what contribution screening has made Finally, in a surprisingly frank summary, they conclude-despite good organisation of the service, much ofour effort in Bristol is devoted to limiting the harm done to healthy women and to protecting our stafffrom litigation, as cases of serious disease continue to occur. The real lesson from 30 years cervical screening is that no matter how obvious the predicted benefit may seem for any screening test, introduction should never take place without adequate prior evaluation of both positive and negative effects in controlled trials. Understandably, this publication provoked a significant response in both the Lancet and in the lay press. As expected, much of the response was critical. Anthony and Clarke4 actually commented that there was no reason to question the value or effectiveness of screening, especially in young women. In his book, Follies CIN.9 It is obvious, therefore, that screening these young women simply unearths an enormous amount of irrelevant "pathology" and, of course, once these young women get referred for colposcopy, the inevitable biopsy often shows a degree of CIN. The reluctance of patients and staff to then adopt a "wait and see" policy inevitably results in some form of destructive treatment to the developing cervix.
There is some concern that the epidemiology of carcinoma of the cervix is changing and that new rapidly progressive carcinomatous 
